MICHAEL MANLEY: Open Payments
NPI 1639403348 · AUGUSTA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 14 payments from 7 companies in 2025. Trend: 2023 $201 · 2024 $210 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $201 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Cranial Technologies, Inc | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: BREZTRI, REXULTI, AIRSUPRA, ZENPEP, Auvelity, Ozempic, Doc Band, QULIPTA.
Industry payments across KS — which companies pay providers there.
